Unregulated ARF6 activation in epithelial cysts generates hyperactive signaling endosomes and disrupts morphogenesis.
Tumor development in glandular tissues is associated with structural alterations in the hollow ducts and spherical structures that comprise such tissues. We describe a signaling axis involving sustained activation of the GTP-binding protein, ARF6, that provokes dramatic changes in the organization of epithelial cysts, reminiscent of tumorigenic glandular phenotypes. In reconstituted basement membrane cultures of renal epithelial cysts, enhanced ARF6 activation induces the formation of cell-filled glandular structures with multiple lumens and disassembled cadherin-based cell-cell contacts. All of these alterations are accompanied by growth factor receptor internalization into signaling endosomes and reversed by blocking ARF6 activation or receptor endocytosis. Receptor localization in signaling endosomes results in hyperactive extracellular signal-regulated kinase signaling leading to Bcl-2 stabilization and aberrant cysts. Similarly, formation of hyperproliferative and disorganized mammary acini induced by chronic stimulation of colony-stimulating factor 1 receptor is coupled to endogenous ARF6 activation and constitutive receptor internalization and is reversed by ARF6 inhibition. These findings identify a previously unrecognized link between ARF6-regulated receptor internalization and events that drive dramatic alterations in cyst morphogenesis providing new mechanistic insight into the molecular processes that can promote epithelial glandular disruption.
Tushir
Jogender S
JS
Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA.
Clancy
James
J
Warren
Andrew
A
Wrobel
Carolyn
C
Brugge
Joan S
JS
D'Souza-Schorey
Crislyn
C
D000089982:ADP-Ribosylation Factor 6; D020727:ADP-Ribosylation Factors / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D002460:Cell Line; D004285:Dogs; D011992:Endosomes / Q000378:metabolism*; D004789:Enzyme Activation; D004847:Epithelial Cells / Q000166:cytology / Q000378:metabolism*; D004848:Epithelium / Q000033:anatomy & histology / Q000196:embryology* / Q000378:metabolism; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism; D006801:Humans; D042361:Mammary Glands, Human / Q000033:anatomy & histology / Q000196:embryology / Q000378:metabolism; D009024:Morphogenesis / Q000502:physiology*; D010739:Phospholipase D / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*
D000089982:ADP-Ribosylation Factor 6; D019253:Proto-Oncogene Proteins c-bcl-2; D048049:Extracellular Signal-Regulated MAP Kinases; D010739:Phospholipase D; D020727:ADP-Ribosylation Factors; C000715348:ARF6 protein, human
Cancer Metastasis Rev. 2008 Mar;27(1):85-94
18175071
Dev Cell. 2006 Jun;10(6):839-50
16740485
FEBS Lett. 2002 Oct 30;531(1):65-8
12401205
J Biochem. 2002 Mar;131(3):301-6
11872157
J Biol Chem. 2006 Jun 9;281(23):15862-8
16595654
Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6647-52
15087504
Annu Rev Med. 1989;40:173-80
2543266
EMBO J. 2001 Sep 3;20(17):4973-86
11532961
Kidney Int. 1999 Jan;55(1):168-78
9893125
Nat Cell Biol. 2002 Dec;4(12):929-36
12447393
Trends Cell Biol. 2005 Jan;15(1):19-26
15653074
EMBO J. 2007 Apr 4;26(7):1806-19
17363898
J Biol Chem. 2000 Jul 14;275(28):21648-52
10801801
J Cell Biol. 2003 Dec 8;163(5):1111-21
14662749
J Mammary Gland Biol Neoplasia. 2004 Oct;9(4):297-310
15838601
J Cell Biol. 2004 Apr 26;165(2):263-73
15117969
Cell. 1995 Oct 20;83(2):279-87
7585945
J Cell Biol. 2008 Nov 17;183(4):625-33
19001128
Nat Rev Cancer. 2004 Feb;4(2):118-32
14964308
Cell Death Differ. 2000 Jul;7(7):654-65
10889510
Cell. 2002 Oct 4;111(1):29-40
12372298
Cell. 2007 Jan 26;128(2):383-97
17254974
Nat Rev Mol Cell Biol. 2002 Jul;3(7):531-7
12094219
FEBS Lett. 2006 Oct 16;580(24):5647-52
16996503
Cancer Res. 1994 Jun 15;54(12):3120-3
8205527
Methods. 2003 Jul;30(3):256-68
12798140
Cancer Res. 2009 Mar 15;69(6):2201-9
19276388
Mol Cancer Res. 2003 Sep;1(11):789-800
14517341
Biochim Biophys Acta. 1994 May 27;1198(1):11-26
8199193
Biochem Biophys Res Commun. 2001 Mar;281(5):1337-42
11243883
Cancer Res. 2009 Feb 1;69(3):794-801
19155310
J Biol Chem. 2007 Jul 27;282(30):21746-57
17540765
J Biol Chem. 2000 Apr 14;275(15):10761-6
10753867
Curr Opin Cell Biol. 2003 Dec;15(6):753-62
14644202
Nat Methods. 2007 Apr;4(4):359-65
17396127
Nat Cell Biol. 2007 Aug;9(8):954-60
17632505
Curr Opin Cell Biol. 2005 Oct;17(5):499-508
16107313
J Exp Med. 1999 Jun 7;189(11):1815-22
10359585
J Biol Chem. 2003 May 9;278(19):17395-400
12609992
Nat Rev Cancer. 2005 Sep;5(9):675-88
16148884
Curr Biol. 2006 Feb 7;16(3):R91-2
16461271
Crit Rev Oncog. 2007 Aug;13(1):39-74
17956217
Trends Cell Biol. 2000 Aug;10(8):343-8
10884687
Cell Cycle. 2008 Jan 1;7(1):57-62
18196964
J Biol Chem. 2002 Jul 26;277(30):27210-6
12016212
Nat Cell Biol. 2006 May;8(5):477-84
16622417
Curr Opin Cell Biol. 2007 Aug;19(4):436-45
17662591
Nat Rev Mol Cell Biol. 2006 May;7(5):347-58
16633337
Nat Cell Biol. 2008 Jan;10(1):85-92
18084281
Mol Cell Biol. 2005 Jun;25(11):4591-601
15899862